Cargando…

Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors

Detalles Bibliográficos
Autores principales:	Spyropoulos, Alex C., Giannis, Dimitrios, Goldin, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268660/ https://www.ncbi.nlm.nih.gov/pubmed/34263101 http://dx.doi.org/10.1002/rth2.12547

Ejemplares similares

Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors
por: Eswaran, Harish, et al.
Publicado: (2021)

Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19
por: Giannis, Dimitrios, et al.
Publicado: (2021)

Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19
por: Spyropoulos, Alex C., et al.
Publicado: (2021)

The underrecognized prothrombotic vascular disease of COVID‐19
por: Cohoon, Kevin P., et al.
Publicado: (2020)

Early thromboembolic events in hospitalized COVID-19 patients
por: Rosen, Raphael J.
Publicado: (2020)

Incidence of thrombotic outcomes for patients hospitalized and discharged after COVID-19 infection
por: Bourguignon, Alex, et al.
Publicado: (2020)

Thromboembolic events following mRNA vaccines for COVID 19: a case series
por: Serrao, Alessandra, et al.
Publicado: (2022)

Longitudinal Evaluation of Health Plan Cost per Venous Thromboembolism or Bleed Event in Patients With a Prior Venous Thromboembolism Event During Hospitalization
por: Bullano, Michael F., et al.
Publicado: (2005)

Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry
por: Giannis, Dimitrios, et al.
Publicado: (2020)

Thromboembolic complications in patients with septic shock requiring invasive mechanical ventilation: Incidence, risk factors, and outcomes
por: Bahloul, Mabrouk, et al.
Publicado: (2020)

The management of venous thromboembolism in hospitalized patients with COVID-19
por: Spyropoulos, Alex C.
Publicado: (2020)

Prevalence of psychiatric morbidity following discharge after COVID-19 hospitalization
por: Wang, Philip R., et al.
Publicado: (2021)

COVID-19 thromboembolism is reduced in ambulatory, but not hospitalized patients, following COVID-19 vaccination
por: Stevens, Hannah, et al.
Publicado: (2023)

Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
por: Spyropoulos, Alex C., et al.
Publicado: (2020)

Incidence of Vascular Thromboembolic Events in Outpatients with Mild COVID-19
por: Eswaran, Harish, et al.
Publicado: (2020)

External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19
por: Goldin, Mark, et al.
Publicado: (2021)

COVID-19-Associated Thromboembolic Events Causing Acute Mesenteric Ischaemia
por: Fan, Bingwen Eugene
Publicado: (2020)

Impact of vaccination status and anticoagulation on venous thromboembolism risk and outcomes in coronavirus disease 2019 patients
por: Volteas, Panagiotis, et al.
Publicado: (2023)

Secondary Polycythemia and the Risk of Venous Thromboembolism
por: Bhatt, Vijaya Raj
Publicado: (2014)

Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19
por: Zhu, Xiangyu, et al.
Publicado: (2021)

Hospital Discharge Data for Guillain-Barré Syndrome and Influenza A (H1N1) Vaccine Adverse Events
por: Jones, Timothy F., et al.
Publicado: (2010)

Twelve‐month risk of thromboembolic events in COVID‐19 hospital survivors in Scotland
por: Farrell, J., et al.
Publicado: (2022)

Letter to the editor: Comment on: High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis
por: Qazi, Maida, et al.
Publicado: (2023)

Reply to :Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19
por: Hamadé, Amer, et al.
Publicado: (2021)

Comment On: The Duration and Magnitude of Postdischarge Venous Thromboembolism Following Colectomy
por: Liang, Yi-di, et al.
Publicado: (2022)

Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS‐CoV‐2
por: Huisman, Albert, et al.
Publicado: (2020)

Dissimilarity in the Frequency of Venous Thromboembolism Risk Factors among Studies, a Commentary
por: Sedaghat, Meghdad, et al.
Publicado: (2018)

eThrombosis: A new risk factor for venous thromboembolism in the pandemic era
por: Sueta, Daisuke, et al.
Publicado: (2020)

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

Incidence of Thromboembolic Events in Cancer Hospitalized Patients With COVID-19
por: Rogado, Jacobo, et al.
Publicado: (2021)

Incidence of Vascular Obstruction After Filler Injections
por: Schelke, Leonie, et al.
Publicado: (2020)

The Risk of Venous Thromboembolism Associated with Oral Contraceptive; the Search Is Still On
por: Abdalvand, Ali
Publicado: (2014)

Lower risk of venous thromboembolism in multiple Asian ethnic groups
por: Nicole Tran, H., et al.
Publicado: (2019)

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry
por: Giannis, Dimitrios, et al.
Publicado: (2021)

Inflammatory biomarkers at hospital discharge are associated with readmission and death in patients hospitalized for COVID-19
por: Slim, Marleen A., et al.
Publicado: (2021)

Venous thromboembolism in hospitalized coronavirus disease 2019 patients stratified by vaccination status
por: Bozzani, Antonio, et al.
Publicado: (2023)

Is There a Relationship Between Olfactory Dysfunction and Decreased Thromboembolic Events After the First Wave of the COVID-19 Pandemic?
por: Akşit, Ercan, et al.
Publicado: (2023)

D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19
por: Choi, Justin J., et al.
Publicado: (2020)

Omalizumab as a Provoking Factor for Venous Thromboembolism
por: Oblitas, Crhistian-Mario, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jkbnndefiu6tbptp4tm1lagou7